Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin

BJU International

Volumn 107, Issue 7, 2011, Pages 1148-1153

  Shiota, Masaki ^a   Tsunoda, Toshiyuki ^a   Song, Yoohyun ^a   Yokomizo, Akira ^a   Tada, Yasuhiro ^a   Oda, Yoshinao ^a   Naito, Seiji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

bladder cancer; cisplatin; S100P

Indexed keywords

CALCIUM BINDING PROTEIN; CISPLATIN; MESSENGER RNA; S100 CALCIUM BINDING PROTEIN P; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG SENSITIVITY; DRUG SENSITIZATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; NEOPLASM PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 79953208052     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09535.x     Document Type: Article

References (40)

1. Hisano T, Ono M, Nakayama M, Naito S, Kuwano M, Wada M,. Increased expression of T-plastin gene in cisplatin-resistant human cancer cells: identification by mRNA differential display. FEBS Lett 1996; 397: 101-7 (Pubitemid 26380183)
2. Yokomizo A, Ono M, Nanri H, et al,. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res 1995; 55: 4293-6
3. Suzuki T, Nishio K, Tanabe S,. The MRP family and anticancer drug metabolism. Curr Drug Metab 2001; 2: 367-77 (Pubitemid 33133981)
4. Eastman A, Schulte N,. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). Biochemistry 1988; 27: 4730-4
5. Masuda H, Ozols RF, Lai GM, Fojo A, Rothenberg M, Hamilton TC,. Increased DNA repair as a mechanism of acquired resistance to cis- diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res 1988; 48: 5713-6
6. Eliopoulos AG, Kerr DJ, Herod J, et al,. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Oncogene 1995; 11: 1217-28
7. Niedner H, Christen R, Lin X, Kondo A, Howell SB,. Identification of genes that mediate sensitivity to cisplatin. Mol Pharmacol 2001; 60: 1153-60 (Pubitemid 33144883)
8. Tsunoda T, Koga H, Yokomizo A, et al,. Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines. Oncogene 2005; 24: 1396-402 (Pubitemid 40343119)
9. Shiota M, Izumi H, Onitsuka T, et al,. Twist promotes tumor cell growth through YB-1 expression. Cancer Res 2008; 68: 98-105 (Pubitemid 351380110)
10. Shiota M, Izumi H, Tanimoto A, et al,. Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth. Cancer Res 2009; 69: 3148-56
11. Miyake H, Hara I, Kamidono S, Gleave ME,. Synergistic chemosensitization and inhibition of tumor growth and metastasis by the antisense ologodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Clin Cancer Res 2001; 7: 4245-52 (Pubitemid 34044651)
12. Djeu JY, Wei S,. Clusterin and chemoresistance. Adv Cancer Res 2009; 105: 77-92
13. Shen DW, Su A, Liang XJ, Pai-Panandiker A, Gottesman MM,. Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells. Br J Cancer 2004; 91: 270-6 (Pubitemid 39037071)
14. Liang XJ, Shen DW, Gottesman MM,. A pleiotropic defect reducing drug accumulation in cisplatin-resistant cells. J Inorg Biochem 2004; 98: 1599-606 (Pubitemid 39349186)
15. Beissel B, Silva ID, Pesquero JB, Russo J, Schor N, Bellini MH,. S-phase reduction in T47D human breast cancer epithelial cells induced by an S100P antisense-retroviral construct. Oncol Rep 2007; 17: 611-5
16. Ishii Y, Kasukabe T, Honma Y,. Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells. Biochim Biophys Acta 2005; 1745: 156-65 (Pubitemid 41207889)
17. Pleger ST, Harris DM, Shan C, et al,. Endothelial S100A1 modulates vascular function via nitric oxide. Circ Res 2008; 102: 786-94 (Pubitemid 351521593)
18. McNeill E, Conway SJ, Roderick HL, Bootman MD, Hogg N,. Defective chemoattractant-induced calcium signalling in S100A9 null neutrophils. Cell Calcium 2007; 41: 107-21 (Pubitemid 44964456)
19. Liang X, Huang Y,. Intracellular free calcium concentration and cisplatin resistance in human lung adenocarcinoma A549 cells. Biosci Rep 2000; 20: 129-38
20. Kotoh S, Naito S, Yokomizo A, et al,. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells. Cancer Res 1994; 54: 3248-52 (Pubitemid 24208937)
21. Kotoh S, Naito S, Yokomizo A, Kohno K, Kuwano M, Kumazawa J,. Enhanced expression of gamma-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype. J Urol 1997; 157: 1054-8 (Pubitemid 27066316)
22. Shiota M, Yokomizo A, Kashiwagi E, et al,. Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin. Cancer Sci 2010; 101: 1177-85
23. Shiota M, Yokomizo A, Masubuchi D, et al,. Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus. Prostate 2010; 70: 540-54
24. Jiang F, Shults K, Flye L, et al,. S100P is selectively upregulated in tumor cell lines challenged with DNA cross-linking agents. Leuk Res 2005; 29: 1181-90 (Pubitemid 41169235)
25. Namba T, Homan T, Nishimura T, Mima S, Hoshino T, Mizushima T,. Up-regulation of S100P expression by non-steroidal anti-inflammatory drugs and its role in anti-tumorigenic effects. J Biol Chem 2009; 284: 4158-67
26. Tang H, Liu YJ, Liu M, Li X,. Establishment and gene analysis of an oxaliplatin-resistant colon cancer cell line THC8307/L-OHP. Anticancer Drugs 2007; 18: 633-9 (Pubitemid 47343655)
27. He Z, Gao J, Wang Q, et al,. S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3. Oncol Rep 2008; 20: 325-32
28. Wang Q, He Z, Gao J, et al,. S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro. Cancer Lett 2008; 272: 277-84
29. Basu GD, Azorsa DO, Kiefer JA, et al,. Functional evidence implicating S100P in prostate cancer progression. Int J Cancer 2008; 123: 330-9 (Pubitemid 351842017)
30. Kolfschoten GM, Hulscher TM, Pinedo HM, Boven E,. Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts. Br J Cancer 2000; 83: 921-7
31. Becker T, Gerke V, Kube E, Weber K,. S100P, a novel Ca(2+)-binding protein from human placenta. cDNA cloning, recombinant protein expression and Ca2+ binding properties. Eur J Biochem 1992; 207: 541-7
32. Guerreiro Da Silva ID, Hu YF, Russo IH, et al,. S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo. Int J Oncol 2000; 16: 231-40
33. Birkenkamp-Demtroder K, Olesen SH, SÃrensen FB, et al,. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 2005; 54: 374-84 (Pubitemid 40299094)
34. Averboukh L, Liang P, Kantoff PW, Pardee AB,. Regulation of S100P expression by androgen. Prostate 1996; 29: 350-5 (Pubitemid 27014349)
35. Logsdon CD, Simeone DM, Binkley C, et al,. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003; 63: 2649-57 (Pubitemid 36605209)
36. Diederichs S, Bulk E, Steffen B, et al,. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res 2004; 64: 5564-9 (Pubitemid 39095550)
37. Arumugam T, Simeone DM, Van Golen K, Logsdon CD,. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res 2005; 11: 5356-64 (Pubitemid 41060808)
38. Gibadulinová A, Baráthová M, Kopácek J, et al,. Expression of S100P protein correlates with and contributes to the tumorigenic capacity of HeLa cervical carcinoma cells. Oncol Rep 2005; 14: 575-82
39. Schor AP, Carvalho FM, Kemp C, Silva ID, Russo J,. S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast. Oncol Rep 2006; 15: 3-6
40. Higgins JP, Kaygusuz G, Wang L, et al,. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol 2007; 31: 673-80 (Pubitemid 46684205)